Afshin Derakhshani

TL;DR: The Global Burden of Disease (GBD) study as discussed by the authors has been used to describe cancer burden for 29 cancer groups in 195 countries from 1990 through 2017 to provide data needed for cancer control planning, including cancer incidence, mortality, years lived with disability, years of life lost, and disability-adjusted life years (DALYs).

TL;DR: Injuries are an important cause of health loss globally, though mortality has declined between 1990 and 2017, and future research in injury burden should focus on prevention in high-burden populations, improving data collection and ensuring access to medical care.

TL;DR: The leading risk factors contributing to global cancer burden in 2019 were behavioural, whereas metabolic risk factors saw the largest increases between 2010 and 2019.

TL;DR: The well-characterized DAMPs are reviewed and focus on the different types of ICD inducers and recent combination therapies that can augment the immunogenicity of cancer cells.

TL;DR: Neutrophil activation and neutrophil degranulation are the most activated biological processes in the SARS infection as well as the neutrophilia, basophilia, and lymphopenia predicted by deconvolution analysis of samples, and using Serpins and Arginase inhibitors during SARS-CoV infection may be beneficial for increasing the survival of Sars-positive patients.